Registration is now open

You won't want to miss the 2025 edition of Practical Applications of New Agents in Oncology

This growing conference is nationally recognized as a place for health care professionals to share and learn about results of clinical studies of new anticancer agents and current treatment strategies. National experts presenting at this conference will be addressing these needs and sharing their knowledge and expert opinion. In addition, attendees will gain the knowledge of how to use pharmacogenomics and personalized medicine approaches to help in the selection of novel new therapies for patients.

The conference will give an up-to-date review of recently approved new agents and promising investigational agents in oncology and hematology and will provide educational opportunities for hematology/oncology fellows, nurse practitioners, physician assistants, registered nurses, pharmacists, and clinical research coordinators. Topics will include combining ADC with immunotherapy, advances in KRAS inhibitors, advances in protein kinase inhibitors, novel therapies in lung cancers, advances in pancreatic cancers and much, much more.

The conference is a continuing education (CME) activity designed for health care professionals specializing in oncology and hematology.